Who
In numbers
- Trades disclosed
- 40
- Buys
- 3
- Sells
- 0
- Bought
- $1.1M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 30 Apr 2021
- Last trade
- 13 Aug 2026
- Last filed
- 14 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Aug 2026filed 14 Aug 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,794 at $0.00 | filing |
| 13 Aug 2026filed 14 Aug 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,794 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,228 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,228 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,271 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,271 at $0.00 | filing |
| 13 Nov 2025filed 14 Nov 2025 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,438 at $0.00 | filing |
| 14 Aug 2025filed 15 Aug 2025 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,790 at $0.00 | filing |
| 22 May 2025filed 23 May 2025 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 22 May 2025filed 23 May 2025 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,741 at $0.00 | filing |
| 27 Feb 2025filed 28 Feb 2025 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,716 at $0.00 | filing |
| 6 Dec 2024filed 9 Dec 2024 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,673 at $0.00 | filing |
| 2 Oct 2024filed 3 Oct 2024 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,295 at $0.00 | filing |
| 7 Jun 2024filed 10 Jun 2024 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —43,394 at $0.00 | filing |
| 29 May 2024filed 31 May 2024 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 11 Mar 2024filed 12 Mar 2024 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,957 at $0.00 | filing |
| 28 Nov 2023filed 29 Nov 2023 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —36,990 at $0.00 | filing |
| 18 Sep 2023filed 19 Sep 2023 | CLNN Cleneoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,321 at $0.00 | filing |
News
Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALSCLNN · manilatimes.net · 19 Oct 2026Head to Head Survey: Shineco (NASDAQ:SISI) vs. Clene (NASDAQ:CLNN)CLNN · tickerreport.com · 8 Oct 2026
0 headlines in the last 90 days name Jonathon Gay; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.